Phenformin is a more potent inhibitor of mitochondrial complex I, with broader tissue bioavailability independent of the Organic Cation Transporter 1 (OCT1) [20] and a more effective anti-tumor effect [21]. Here, SLC22A1 is linked to neoplasm.